Article ID Journal Published Year Pages File Type
3269757 HPB 2011 8 Pages PDF
Abstract
Prostate stem cell antigen is frequently expressed on pancreatic cancer cells and can be targeted for immune-mediated destruction using CAR-modified, adoptively transferred T cells. The safety and efficacy of this approach indicate that it deserves further study and may represent a promising novel treatment for patients with pancreatic cancer.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Endocrinology, Diabetes and Metabolism
Preview
Engineered T cells for pancreatic cancer treatment
Authors
, , , , , , ,